Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
China
· Delayed Price · Currency is CNY 44.29
+0.81 (1.86%)
Mar 9, 2026, 4:00 PM EDT
SHA:688273 Market Cap
SHA:688273 has a market cap or net worth of 4.33 billion as of March 9, 2026. Its market cap has increased by 80.61% in one year.
Market Cap
4.33B
Enterprise Value
3.56B
Revenue
431.59M
Ranking
n/a
PE Ratio
42.45
Stock Price
44.29
Market Cap Chart
Since August 11, 2022, SHA:688273's market cap has decreased from 4.41B to 4.33B, a decrease of -1.70%. That is a compound annual growth rate of -0.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 4.33B | 4.16% |
| Dec 31, 2025 | 4.16B | 81.85% |
| Dec 31, 2024 | 2.29B | -31.77% |
| Dec 29, 2023 | 3.35B | 2.81% |
| Dec 30, 2022 | 3.26B | -26.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getein Biotech | 4.25B |
| Ningbo David Medical Device | 4.11B |
| Shanghai Kinetic Medical | 4.43B |
| Wuhan Easy Diagnosis Biomedicine | 4.06B |
| Zhejiang Orient Gene Biotech | 4.50B |
| Medprin Regenerative Medical Technologies | 4.60B |
| Hangzhou AGS MedTech | 4.69B |
| Beijing Leadman Biochemistry | 3.74B |